Kate Blanco

Dr. Kate Blanco


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JWJace A. Willis
Jace A. Willis
VCVsevolod Cheburkanov
Vsevolod Cheburkanov
SCShaorong Chen
Shaorong Chen
JSJennifer M. Soares
Jennifer M. Soares
GKGiulia Kassab
Giulia Kassab
VYVladislav Yakovlev
Vladislav Yakovlev
The widespread use of antibiotics drives the evolution of antimicrobial-resistant bacteria (ARB), threatening patients and healthcare professionals. Therefore, the development of novel strategies to combat resistance is recognized as a global healthcare priority. The two methods to combat ARB are development of new antibiotics or reduction in existing resistances. Development of novel antibiotics is a laborious and slow-progressing task that is no longer a safe reserve against looming risks. In this research, we suggest a method for reducing resistance to extend the efficacious lifetime of current antibiotics. Antimicrobial photodynamic therapy (aPDT) is used to generate reactive oxygen species (ROS) via the photoactivation of a photosensitizer. ROS then nonspecifically damage cellular components, leading to general impairment and cell death. Here, we test the hypothesis that concurrent treatment of bacteria with antibiotics and aPDT achieves an additive effect in the elimination of ARB. Performing aPDT with the photosensitizer methylene blue in combination with antibiotics chloramphenicol and tetracycline results in significant reductions in resistance for two methicillin-resistant Staphylococcus aureus (MRSA) strains, USA300 and RN4220. Additional resistant S. aureus strain and antibiotic combinations reveal similar results. Taken together, these results suggest that concurrent aPDT consistently decreases S. aureus resistance by improving susceptibility to antibiotic treatment. In turn, this development exhibits an alternative to overcome some of the growing MRSA challenge.

31 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AZAmanda C. Zangirolami
Amanda C. Zangirolami
LDLucas D. Dias
Lucas D. Dias
KBKate Blanco
Kate Blanco
CVCarolina S. Vinagreiro
Carolina S. Vinagreiro
NINatalia Mayumi Inada
Natalia Mayumi Inada
VBVanderlei Salvador Bagnato
Vanderlei Salvador Bagnato
Hospital-acquired infections are a global health problem that threatens patients’ treatment in intensive care units, causing thousands of deaths and a considerable increase in hospitalization costs. The endotracheal tube (ETT) is a medical device placed in the patient’s trachea to assist breathing and delivering oxygen into the lungs. However, bacterial biofilms forming at the surface of the ETT and the development of multidrug-resistant bacteria are considered the primary causes of ventilator-associated pneumonia (VAP), a severe hospital-acquired infection for significant mortality. Under these circumstances, there has been a need to administrate antibiotics together. Although necessary, it has led to a rapid increase in bacterial resistance to antibiotics. Therefore, it becomes necessary to develop alternatives to prevent and combat these bacterial infections. One possibility is to turn the ETT itself into a bactericide. Some examples reported in the literature present drawbacks. To overcome those issues, we have designed a photosensitizer-containing ETT to be used in photodynamic inactivation (PDI) to avoid bacteria biofilm formation and prevent VAP occurrence during tracheal intubation. This work describes ETT’s functionalization with curcumin photosensitizer, as well as its evaluation in PDI against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. A significant photoinactivation (up to 95%) against Gram-negative and Gram-positive bacteria was observed when curcumin-functionalized endotracheal (ETT-curc) was used. These remarkable results demonstrate this strategy’s potential to combat hospital-acquired infections and contribute to fighting antimicrobial resistance. Significance Hospital-acquired infections also caused by multidrug-resistant bacteria are currently one of the most severe problems that our society faces, which constitute an excellent risk for humankind. The absence of alternatives to combat these types of infections leaves humanity highly vulnerable. Therefore, it becomes imperative to develop new technologies to fight bacterial infections, with alternative mechanisms of action relative to the classical antibiotics. Since ventilator-associated pneumonia (VAP) occurs in patients under mechanical ventilation, an urgent need is needed to prevent, decrease, and combat infectious pathogens at the endotracheal tube (ETT). In this paper, we demonstrate a practical methodology to prepare a regular photosensitizer-containing ETT, with effective photodynamic activity for microbial inactivation. The process is efficient and safe for the patient.

18 May 2021 in Applied Physics Reviews
Verified
Journal Article
Closed access
PDF file
JWJace A. Willis
Jace A. Willis
VCVsevolod Cheburkanov
Vsevolod Cheburkanov
GKGiulia Kassab
Giulia Kassab
JSJennifer M. Soares
Jennifer M. Soares
KBKate Blanco
Kate Blanco
VYVladislav Yakovlev
Vladislav Yakovlev
Antibiotic-resistant bacteria, which are growing at a frightening rate worldwide, has put the world on a long-standing alert. The COVID-19 health crisis reinforced the pressing need to address a fast-developing pandemic. To mitigate these health emergencies and prevent economic collapse, cheap, practical, and easily applicable infection control techniques are essential worldwide. Application of light in the form of photodynamic action on microorganisms and viruses has been growing and is now successfully applied in several areas. The efficacy of this approach has been demonstrated in the fight against viruses, prompting additional efforts to advance the technique, including safety use protocols. In particular, its application to suppress respiratory tract infections and to provide decontamination of fluids, such as blood plasma and others, can become an inexpensive alternative strategy in the fight against viral and bacterial infections. Diverse early treatment methods based on photodynamic action enable an accelerated response to emerging threats prior to the availability of preventative drugs. In this review, we evaluate a vast number of photodynamic demonstrations and first-principle proofs carried out on viral control, revealing its potential and encouraging its rapid development toward safe clinical practice. This review highlights the main research trends and, as a futuristic exercise, anticipates potential situations where photodynamic treatment can provide a readily available solution.

20 September 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JSJennifer Machado Soares
Jennifer Machado Soares
VYVladislav Yakovlev
Vladislav Yakovlev
KBKate Blanco
Kate Blanco
VBVanderlei Salvador Bagnato
Vanderlei Salvador Bagnato
Multidrug-resistant bacteria are one of the most serious threats to infection control. Few new antibiotics have been developed; however, the lack of an effective new mechanism of their action has worsened the situation. Photodynamic inactivation (PDI) can break antimicrobial resistance, since it potentiates the effect of antibiotics, and induces oxidative stress in microorganisms through the interaction of light with a photosensitizer. This paper addresses the application of PDI for increasing bacterial susceptibility to antibiotics and helping in bacterial persistence and virulence. The effect of photodynamic action on resistant bacteria collected from patients and bacteria cells with induced resistance in the laboratory was investigated. Staphylococcus aureus resistance breakdown levels for each antibiotic (amoxicillin, erythromycin, and gentamicin) from the photodynamic effect (10 µM curcumin, 10 J/cm 2 ) and its maintenance in descendant microorganisms were demonstrated within five cycles after PDI application. PDI showed an innovative feature for modifying the degree of bacterial sensitivity to antibiotics according to dosages, thus reducing resistance and persistence of microorganisms from standard and clinical strains. We hypothesize a reduction in the degree of antimicrobial resistance through photooxidative action combats antibiotic failures.

1 March 2018 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
TAThalita Santos Dantas Araújo
Thalita Santos Dantas Araújo
PRPaôlla Layanna Fernandes Rodrigues
Paôlla Layanna Fernandes Rodrigues
MSMariana Sousa Santos
Mariana Sousa Santos
JOJaneide Muritiba de Oliveira
Janeide Muritiba de Oliveira
LRLuciano Pereira Rosa
Luciano Pereira Rosa
FSFrancine Cristina da Silva
Francine Cristina da Silva

30 April 2015 in Frontiers in Physics
Verified
Journal Article
Open access
PDF file
KBKate Blanco
Kate Blanco
LMLilian Tan Moriyama
Lilian Tan Moriyama
NINatalia Mayumi Inada
Natalia Mayumi Inada
ASAna G. Sálvio
Ana G. Sálvio
PMPriscila F. C. Menezes
Priscila F. C. Menezes
VBVanderlei S. Bagnato
Vanderlei S. Bagnato
The photodynamic therapy (PDT) is an alternative technique that can be indicated for superficial basal cell carcinoma (sBCC), Bowen’s disease and actinic keratosis with high efficiency. The objective of this study is to present the importance of fluorescence imaging for PDT guidance and monitoring in real time. Confirming that the lesion is well prepared and the photosensitizer shows a homogenous distribution, the outcome after few PDT sessions will be positive and the recurrence should be lower. Our proposition in this study is use the widefield fluorescence imaging to evaluate the PDT protocol in situ and in real time for each lesion. This evaluation procedure is performed in two steps: first with the monitoring of the production of protoporphyrin IX (PpIX) induced by methyl aminolevulinate (MAL), an derivative of 5-aminolevulinic acid (ALA) and second with the detection of PpIX photobleaching after illumination. The fluorescence images provide information correlated with distinct clinical features and with the treatment outcome. Eight BCC lesions are presented and discussed in this study. Different fluorescence patterns of PpIX production and photobleaching could be correlated with the treatment response. The presented results show the potential of using widefield fluorescence imaging as a guidance tool to customized PDT.